|
Commercial Product |
Indication |
CAS |
Specification |
GMP |
Documentation |
 |
Gabapentin |
Anti-epilepsy / Pain treatment |
60142-96-3 |
EP/USP |
EIR, EUGMP, local GMP, WC |
USDMF,CEP,TDMF, CAN-DMF, KDMF |
 |
Celecoxib |
Anti-inflammatory |
169590-42-5 |
EP/USP |
EIR, EUGMP, local GMP, WC |
USDMF,CEP,TDMF, CAN-DMF, KDMF |
 |
Rebamipide |
Gastrointestinology |
90098-04-7 |
JP/JPC |
PMDA,MFDS,local GMP, WC |
JDMF, KDMF, USDMF |
 |
Aceclofenac |
Anti-inflammatory |
89796-99-6 |
EP/BP |
local GMP, WC |
USDMF, CEP, KDMF,TDMF |
 |
Candesartan Cilexetil |
Anti-hypertension |
145040-37-5 |
EP/USP/JP |
EUGMP, local GMP, WC |
USDMF, CEP, JDMF, TDMF |
 |
Ticagrelor |
Anti-thrombotics |
274693-27-5 |
EP |
local GMP, WC |
USDMF #31620, CEP processing |
 |
Rivaroxaban |
Anti-thrombotics |
366789-02-8 |
EP |
local GMP, WC |
USDMF #31601, CEP processing |
 |
Dabigatran Etexilate Mesylate |
Anti-thrombotics |
872728-81-9 |
in house |
local GMP, WC |
USDMF #32782 |
 |
Vildagliptin |
Anti-diabetes |
274901-16-5 |
in house |
local GMP, WC |
USDMF #31663, EU/ASMF/00254 |
 |
Febuxostat |
Anti-gout |
144060-53-7 |
in house |
local GMP, WC |
USDMF #32780 |
 |
Azilsartan |
Anti-hypertension |
147403-03-0 |
in house |
local GMP, WC |
JDMF |
 |
Atazanavir Sulfate |
Anti-Virus |
229975-97-7 |
in house |
local GMP, WC |
DMF available |
|